Total Payments
$13,823
2024 Payments
$2,462
Companies
62
Transactions
871
Medicare Patients
4,410
Medicare Billing
$467,883
Payment Breakdown by Category
Food & Beverage$13,785 (99.7%)
Education$38.47 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,785 | 864 | 99.7% |
| Education | $38.47 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,289 | 93 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,149 | 64 | $0 (2024) |
| PFIZER INC. | $1,066 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,023 | 66 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,002 | 64 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $764.29 | 54 | $0 (2023) |
| Lilly USA, LLC | $637.44 | 42 | $0 (2024) |
| Amgen Inc. | $599.33 | 50 | $0 (2024) |
| ABBVIE INC. | $575.03 | 36 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $568.83 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,462 | 132 | GlaxoSmithKline, LLC. ($307.61) |
| 2023 | $2,643 | 162 | Lilly USA, LLC ($283.69) |
| 2022 | $1,527 | 92 | Boehringer Ingelheim Pharmaceuticals, Inc. ($203.06) |
| 2021 | $1,141 | 69 | Novo Nordisk Inc ($175.75) |
| 2020 | $617.20 | 43 | Novo Nordisk Inc ($135.03) |
| 2019 | $1,396 | 96 | Janssen Pharmaceuticals, Inc ($218.78) |
| 2018 | $2,071 | 137 | PFIZER INC. ($213.12) |
| 2017 | $1,965 | 140 | AstraZeneca Pharmaceuticals LP ($240.67) |
All Payment Transactions
871 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: VACCINES | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.33 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.30 | General |
| Category: Cardiovascular | ||||||
| 11/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: ANTI-DIABETIC | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,198 | 1,673 | $388,066 | $122,615 |
| 2022 | 15 | 1,086 | 1,663 | $399,677 | $118,203 |
| 2021 | 12 | 1,028 | 1,645 | $410,913 | $122,082 |
| 2020 | 18 | 1,098 | 1,737 | $420,403 | $104,983 |
Total Patients
4,410
Total Services
6,718
Medicare Billing
$467,883
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 333 | 672 | $216,950 | $58,766 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 265 | 265 | $89,835 | $33,655 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 159 | $34,596 | $9,489 | 27.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $8,734 | $6,199 | 71.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 65 | 65 | $5,850 | $4,675 | 79.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 67 | 67 | $4,020 | $2,030 | 50.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $7,500 | $1,736 | 23.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 37 | 43 | $7,181 | $1,641 | 22.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 142 | 181 | $1,629 | $1,520 | 93.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 17 | 26 | $3,328 | $779.04 | 23.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $1,320 | $666.93 | 50.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 59 | $4,307 | $599.94 | 13.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 12 | $1,011 | $415.44 | 41.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 23 | 23 | $450.34 | $205.92 | 45.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $1,105 | $180.96 | 16.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 25 | $250.00 | $55.00 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 335 | 761 | $245,803 | $65,712 | 26.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 208 | 208 | $70,512 | $26,996 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 190 | $41,420 | $11,693 | 28.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 64 | 66 | $5,940 | $4,504 | 75.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $12,500 | $2,518 | 20.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 69 | 71 | $4,260 | $2,052 | 48.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 27 | 38 | $6,346 | $1,524 | 24.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 17 | 25 | $3,200 | $775.47 | 24.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 69 | $5,037 | $717.29 | 14.2% |
About Dr. Vasu Nalajala, MD
Dr. Vasu Nalajala, MD is a Family Medicine healthcare provider based in Bedford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326096900.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vasu Nalajala, MD has received a total of $13,823 in payments from pharmaceutical and medical device companies, with $2,462 received in 2024. These payments were reported across 871 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($13,785).
As a Medicare-enrolled provider, Nalajala has provided services to 4,410 Medicare beneficiaries, totaling 6,718 services with total Medicare billing of $467,883. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Internal Medicine
- Location Bedford, TX
- Active Since 05/05/2006
- Last Updated 09/09/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1326096900
Products in Payments
- FARXIGA (Drug) $705.43
- JARDIANCE (Drug) $640.62
- XARELTO (Drug) $603.41
- Ozempic (Drug) $532.48
- Kerendia (Drug) $518.75
- VRAYLAR (Drug) $504.47
- ENTRESTO (Drug) $485.91
- ELIQUIS (Drug) $457.28
- TRELEGY ELLIPTA (Drug) $360.78
- MOUNJARO (Drug) $355.38
- SHINGRIX (Biological) $302.35
- LINZESS (Drug) $246.12
- ANORO (Drug) $240.98
- Vascepa (Drug) $234.43
- XIFAXAN (Drug) $233.52
- NURTEC ODT (Drug) $221.70
- Rybelsus (Drug) $221.26
- FREESTYLE LIBRE 3 (Device) $217.47
- AREXVY (Drug) $196.48
- CHANTIX (Drug) $192.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bedford
Munawar Haider, Md, MD
Family Medicine — Payments: $14,495
Family Medicine $14,495
Dr. Charles Cook, D.o, D.O
Family Medicine — Payments: $12,048
Family Medicine $12,048
Dr. Kara Matala, D.o, D.O
Family Medicine — Payments: $11,758
Family Medicine $11,758
Mrs. Uzoamaka Obinabo, M.d, M.D
Family Medicine — Payments: $9,408
Family Medicine $9,408
Diane Rowell, Md, MD
Family Medicine — Payments: $8,868
Family Medicine $8,868
Ajay Koshy, Md, MD
Family Medicine — Payments: $5,816
Family Medicine $5,816